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1. Introduction 
Lyme disease is a tick-borne systemic illness caused by three pathogenic species of the 
spirochete Borrelia burgdorferi sensu lato (B. burgdorferi sensu stricto, B. afzelii and B. garinii). 
They are flagellated bacteria close to Treponema pallidum, the ethiologic agent of syphilis. All 
three pathogenic species occur in Europe, Ixodes ricinus being the tick responsible for their 
transmission in this area. Two of the Borrelia species (B. afzelii and B. garinii) have been 
identified in Asia. B. burgdorferi is the sole cause of the disease in the United States. 
Although in United States the proportion of neuroborreliosis among Lyme disease 
manifestations is of about 8%, in Europe the incidence of this form of disease is more 
elevated 16-46% (1).  
Lyme disease has a broad spectrum of clinical manifestations, and variable degrees of 
severity due, in part, to differences in the infecting species. In France, for example, 
neurologic manifestations of Lyme disease are frequent due to the endemic presence of B. 
garinii (2). Historically, the first case of neuroborreliosis in medical literature was described 
in 1922 in Lyon: meningoradiculitis, preceded by a tick bite and migratory erithema, in a 
patient who presented a false positive syphilis serology. Meningoraticulitis remains even 
today the most frequent form of neurolyme, even though the known spectrum of disease 
can be very broad, varying from mild impairment to severe, cognitive or even psychiatric 
manifestations. Phenomenology-based assertions that "Lyme disease can do anything" in the 
nervous system or that Lyme disease is the new “grand imitator”, make difficult the task of 
differentiating between true nervous system disorders and the effects of extra-neurologic 
disease on behavior and cognitive function. 
In this section the neurologic manifestations of Lyme disease, with special emphasis on 
Lyme meningitis, encephalomyelitis will be reviewed. The definition of a controversial 
entity - Lyme encephalopathy - will be discussed. Much of the confusion and controversy 
surrounding Lyme disease relates to misunderstandings about what does and does not 
constitute evidence of nervous system infection. Emphasis on several nonspecific symptoms 
in early studies (3,4) led to sometimes erroneous conclusions regarding symptoms specific 
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for Lyme disease. This misunderstanding was one of the elements that contributed to 
debatable attitudes regarding which individuals required treatment for Lyme disease, what 
constituted effective treatment, and how to define cure (5). 
In order to have an accurate understanding of nervous system Lyme disease the true scope 
of nervous system disorders attributable to Lyme disease and their corresponding 
pathophysiologic mechanisms, need to be better defined.  
2. Epidemiological background 
Epidemiological context is essential to establishing the diagnosis of Lyme disease. Even so, it 
is not always easily highlighted. 
Following the infestation of a tick during a meal on an infected mammal, Borrelia will 
develop inside the acarian and will accidentally be transmitted to a human host. 
Transmission will mostly occur in a humid environment (forest, field, even garden). The risk 
of transmission is proportional to the duration of tick attachment: at least 12 hours are 
necessary in order for the Borrelia to reach the salivary glands of the tick. The bite of Ixodes 
ricinus is painless and the larva tick measures up to 1 mm. Consequently tick bites are 
discovered in only 26-38% patients (6,7). 
Few studies have looked into the different clinical patterns seen with different Borrelia 
species. Strle et al has shown in a study of 33 european patients in which Borrelia could be 
isolated in culture, that B. garinii was mostly associated with meningitis symptoms (61% for 
B. garinii versus 10% for B. afzelii, p=0,009) and painful radicular symptoms (65% versus 
0%, p<0.001), while neurocognitiv impairment seemed more frequent in patients infected 
with B. afzelii, even though statistical significance was not proven (8). 
There are two age incidence peaks: in childhood and between 50-60 years of age. Males are 
1,5 times more often infected than females. The first manifestations of the diseases develop 
most often in spring-autumn, especially in June - November (6,7).  
The early, localized phase, occurring a few days to one month after the tick bite consists in 
migratory erythema. The diameter of the lesion can range from a few millimeters to tens of 
centimeters. It is mostly annular, but can be polymorphe and can be easily mistaken for the 
local inflammatory reaction at the site of the bite or can remain unperceived (9). 
Consequently migratory erythema is noted in less than half of the patients (18-46%) (9). 
Associated symptoms and signs during this early, localized, stage may include: fatigue, 
malaise, lethargy, mild headache, mild neck stiffness, myalgias, arthralgias and/or regional 
lymphadenopathy. 
3. Clinical spectrum of neuroborreliosis 
Neuroborreliosis is found either in the context of an early disseminated disease or during 
late, chronic Lyme disease. The clinical features of nervous system Lyme disease, although 
proteiform?, have certain characteristics. Clinical features of Lyme disease may be a result of 
direct bacterial infection (particularly in the early stages of disease) or a consequence of the 
immune response leading to symptoms in different organs. 
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Just as in neurosyphilis, nervous system involvement begins during early disseminated 
Lyme disease, when spread of the spirochetes can result in meningeal seeding (10). As in 
syphilis, untreated Borrelia infection probably subsides in some patients but becomes 
chronic in others. Also as in syphilis, appropriate antimicrobial treatment results in 
microbiologic cure in the overwhelming majority of patients, regardless of the duration of 
the infection. 
Neurologic features of early disseminated Lyme, developing at weeks to months after tick 
bite disease may include: 
 Lymphocytic meningitis 
 Unilateral or bilateral cranial nerve palsies (especially of the facial nerve) 
 Radiculopathy 
 Peripheral neuropathy 
 Mononeuropathy multiplex 
 Cerebellar ataxia (rarely) 
 Encephalomyelitis (rarely) 
They can occur in the absence of any prior features of Lyme disease. The classic triad of 
acute neurologic abnormalities is meningitis, cranial neuropathy, and motor or sensory 
radiculoneuropathy, although each of these findings may occur alone (5). 
Although the facial nerve is the most commonly affected cranial nerve, other nerves such as 
the abducens nerve may be involved. Lyme disease is one of the few causes of bilateral 
cranial nerve palsies. Other causes include tuberculosis, sarcoidosis, and trauma. 
The neurologic manifestations of late Lyme disease are different from those in early 
disseminated disease. They occur month to years after tick bite and in the absence of any 
prior features of Lyme disease and only about 25 percent of patients with erythema migrans 
recall the tick bite that transmitted Lyme disease (6, 7). In the United States, a mild 
neurologic syndrome, called Lyme encephalopathy, has been reported, manifested 
primarily by subtle cognitive disturbances (11,12). In the United States and Europe, a 
chronic axonal polyneuropathy may develop, manifested primarily as spinal radicular pain 
or distal paresthesias (7,11,12). In Europe, B. garinii may rarely cause chronic 
encephalomyelitis, characterized by spastic paraparesis, cranial neuropathy, or cognitive 
impairment with marked intrathecal antibody production to the spirochete (7).  
It is unknown whether the time course of these syndromes is related to differences in 
spirochetal strain, inoculum size, or host response. However, the syndromes associated with 
abrupt onset typically occur early in infection (within the first few months), whereas those 
that are more indolent and protracted often present later in the course (eg, many months 
after initial infection) (5). Consideration of the clinical findings of nervous system Lyme 
disease is divided into disorders of the peripheral versus central nervous systems. In both, 
the predominant mechanism appears to be multifocal inflammatory involvement of the 
affected structure, be it patchy peripheral nerve involvement or, rarely, patchy inflammation 
of the central nervous system. 
Regardless of the clinical syndrome, a frequently found accompanying feature of 
disseminated disease is radicular pain, reported in 38% to up to 86% of patients with 
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neuroborreliosis (6,7,9). Headache is also found in 18-43%, neck stiffness is almost exlusively 
found in children, while arthralgias are described in only 1-18% of patients and myalgias are 
rarely found, in up to 13% patients with neuroborreliosis (6,7). Fever is noted in 10% of 
patients. Other very rare manifestations are: myocarditis with atriventricular block (1%), 
atrophic acrodermatitis (dermatologic features of chronic diseases, found in less than 1% of 
patients with neuroborreliosis, in large cohorts) and chorioretinitis (6,7,9). 
4. Acute meningoradiculitis and meningitis  
The two largest European studies published to date, on a total of 187 patients (Hansen et al, 
Danmark) and 330 patients (Oschmann et al, Germany), reported meningoradiculitis as the 
predominant form of neuroborreliosis (with an incidence of 67% and 85% respectively) (6,7). 
The delay between the tick bite and the neurologic syndrome is, in average, 3 weeks, but can 
extend to more than three months (6). The typical, but non compulsory, sequence is: 
migratory erythema at 3 days after the bite, sensitive radiculitis 3 weeks after, than paresis 
in the two following weeks, with or without the apparition of new radicular impairment (6). 
In the European literature, involvement is said to parallel the site of the tick bite (14); this 
has not been addressed systematically in the United States. Pain is often a prominent 
element, the hallmark of the syndrome. It can be described as severe, “burn”, “tear” or 
painful paresthesias, more accentuated at night and preventing sleep (9). Pain is not always 
confined to strict radicular topography, is accompanied by hypo/disesthesia, local or diffuse 
and is not easily alleviated by usual painkillers, including opiods (9). Only antibiotic 
treatment by ceftriaxone can lead to a resolution of the symptoms. This disorder can mimic a 
mechanical radiculopathy (eg, sciatica) with radicular pain in one or several dermatomes, 
accompanied by corresponding sensory, motor and reflex changes, but the presence of such 
deficits is not constant, even in the presence of subjective complaints. Lyme disease should 
be considered in patients in endemic areas presenting in spring through autumn with severe 
limb or truncal radicular pain without an apparent mechanical precipitant (5). In European 
neuroborreliosis, the term Garin-Bujadoux-Bannwarth syndrome (or Bannwarth syndrome) 
has been applied to the constellation of painful radiculoneuritis, often accompanied by 
meningitis with minimal headache and sometimes with cranial neuropathy (15).  
In more than 50% of cases meningoradiculitis are accompanied by cranial nerves 
involvement (7). The spectrum of Lyme cranial neuropathies will not be detailes here, but 
facial nerve involvement represents about 80-90 percent of all Lyme disease-associated 
cranial neuropathies (6). Since facial nerve palsy is uncommon in children, Lyme disease 
should be strongly considered as the cause of facial nerve palsy affecting a child who has 
been in an endemic area. In adults in endemic areas, during spring through fall, a significant 
percentage of facial nerve palsies are attributable to Lyme disease. In one study in an 
endemic region, one quarter of cases of facial nerve palsy in the summer were likely due to 
Lyme disease, based upon serologies (16). Involvement can be bilateral, with onset being 
either simultaneous or in rapid succession. Because bilateral facial nerve palsies are 
generally uncommon, such cases should bring Lyme disease to mind in patients with 
potential recent exposure. The differential diagnosis of bilateral facial nerve palsies is 
limited and includes sarcoidosis, Guillain-Barré syndrome, HIV infection and other basilar 
meningitides (5). 
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Cerebrospinal fluid analysis is essential to the diagnosis of meningoradiculitis, but the 
findings are non specific. Most often there is increased cellularity, with lymphocytic 
predominance, similar to viral meningitis. Hyperproteinorahia (frequently around 1g/l, but 
can be normal or as elevated as 5g/l) and IgG oligoclonal bands can be found in 70% of 
cases (7). When accompanied by peripheric involvement, axonal damage can by proven by 
EMG. MRI can show enhancement of spinal or cranial nerve roots. Usually though the 
clinical picture and the lumbar puncture are sufficient for guiding the diagnosis (9). 
The clinical spectrum can include several atypical forms as: ataxic sensitive neuropathy with 
meningitis, multiple neuropathy with meningitis or motor polyradiculoneuritis with 
meningitis (9).  
Isolated meningitis represents only 4-5% of neuroborreliosis and is more frequently found in 
children (6,7). In this setting, headache is rarely severe and the meningitic syndrome, if 
present, is never as serious as in purulent meningitis. Fever is reported in 4-10% of patients 
with isolated meningitis and migratory erythema in only 17% of cases (7). 
Due to their quiet clinical appearance, these acute meningitis forms can remain undiagnosed 
and progress to chronic infection. The term “chronic” is used when the duration of 
symptoms extends beyond 6 months, in which case other organic symptoms, such as weight 
loss, can be present (7,9). 
CSF study in isolated meningitis has the same features as in meningoradiculitis. Pleiocytosis 
is around 200/mm3 and the presence of oligoclonal bands is less frequent (around only 22% 
of cases) (7). Hypoglycorahia can be an important finding, raising the need for a differential 
diagnosis with tuberculosis. In this context of nonspecific findings, the essential diagnostic 
tool is the intrathecal anti-Borrelia antibody index (17), which will be described later in this 
section. 
Interestingly, certain tick species are able to transmit both tick-borne encephalitis (TBE) and 
Lyme borreliosis. Therefore, it is possible that a patient can simultaneously be infected with 
the TBE-virus and Borrelia burgdorferi-spirochete as a result of a single tick bite. Although 
this is a rare event, its possibility has to be taken into account, since only neuroborreliosis 
beneficiates from a specific treatment 
Benign intracranial hypertension — A pseudotumor cerebri-like picture (benign 
intracranial hypertension) occurs with increased frequency in children with Lyme disease 
(18,19). Virtually all of the reported cases have had inflammatory cerebrospinal fluid, 
suggesting that the increased intracranial pressure is a result of meningitis, in 
contradistinction to the usual picture of pseudotumor with a normal cerebrospinal fluid 
profile. Regardless of the mechanism, the symptoms and potential consequences are 
identical, including compression of cranial nerves with a particular threat to the optic nerves 
and vision (5). 
5. Acute myelitis 
In the two large European cohort studies mentioned above acute myelitis are reported in 4-
5% of cases (6,7). They are associated in 35% of cases with a cranial radiculopathy and in 
59% of cases with spinal neuropathy. Fever is present in 6% of cases. The medullar 
syndrome includes: paraparesis (75% of cases), proprioceptive ataxia (35% of cases), urinary 
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dysfunction (20% of cases) (7). Although reported in a majority of cases, CSF pleyocytosis is 
not a constant finding. There are only 12 published cases describing a medullar MRI (20). By 
the time this localization is proven, it usually involves more than three metamers. The 
localization is most often cervical, high thoracic or cervico-thoracic, but the exact pattern can 
be variable (most cited: transverse myelitis and predominantly posterior myelitis) (20). 
Sometimes, when myelitis is not proven on MRI, leptomeningeal enhancement, coupled 
with clinical data, will orient towards the diagnosis. 
6. Acute encephalitis 
Acute encephalitis and meningoencephalitis represents only 0,5-8% of neurolyme in Europe 
(6,7). Headache is present in two thirds of cases. In 40-50% of patients radicular pain, cranial 
neuropathies (mostly VI and VII), as well as fever, are part of the clinical picture (7). On the 
other hand, in 57 % of cases encephalitis presents as acute neuropsychiatric disease: 
cognitive of memory impairment, disorientation, depression or sleep disorder. In 21% of 
cases cerebral ataxia has been described. An asymmetric extrapyramidal syndrome is 
present in 21% of patients and hemiparesis in 7% of cases (7). The consciousness level is 
rarely and only mildly impaired.  
CSF analysis shows lymphocytic pleyocytosis than can be modest, of only a few cells. 
Proteinorahia is less often elevated and can be normal. The presence of IgG oligoclonal 
bands in CSF is proven in up to 55% of cases (7).  
Noteworthy, the electroencephalogram (EEG) is abnormal in all patients: a moderate 
slowing with generalized slow waves with or without spikes is most often found. In 14% of 
patients slow theta-delta waves can be found (7). Seizures are present in up to 4% of 
patients. The cerebral CT is normal in most cases, as is the MRI. Hypersignal T2 temporal or 
brainstem lesions have been described (7). 
7. Acute optic neuropathy 
This is an extremely rare manifestation of Lyme disease, which can be circumscribed to the 
spectrum of neuroborreliosis. In a study of 440 patients with optic neuropathy, Sibony et al 
found the presence of Lyme disease in only 2 patients (21). There are only 2 other cases of 
isolated Lyme optic neuropathy described in literature. Nine other cases of associations 
between optic neuropathy and other neurologic features of Lyme disease have been 
reported. In the majority of these cases a positive intratechal anti-Borrelia antibody index 
was found, accompanied in less than half of the cases by CSF pleyocytosis. The antibiotic 
treatment led to the amelioration of visual symptoms, even when a delay of a few months 
existed between the clinical onset and the initiation of treatment (22,23). Lyme disease as a 
cause of optic neuropathy may be underdiagnosed. 
8. Cerebrovascular disease 
Presenting as both acute and chronic manifestations, cerebrovascular disease is rare, around 
1% of neurolyme cases (7). Ischemic disease, transitory or not, seems to be more frequent, 
preceded by symptoms of progressive encephalopathy with headache, cognitive 
impairment and behavioral changes or cranial neuropathy (7). In a recently described case 
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of ischemic neuroborreliosis the patient complained for two years of acustic impairment, for 
which no etiology was found (24). Ischemic lesions seem to be more frequently localized in 
the basal ganglia, the vertebrobassilar system or the subcortical regions. Diffuse or local 
stenosis can be proven on angio MRI (7,24). In this context CSF study will show a 
lymphocytic pleyocytosis with hyperproteinorahia and oligoclonal bands. 
Hemorrhagic vascular lesions have been described in only a few case-reports: 4 cases of 
subarachnoid hemorrhage, 3 cerebral and 1 medullary, 2 cases of intracerebral hematomas 
and one atypical case associating myelitis and meningeal hemorrhage (20). One pathology 
study showed an important lymphocytic perivascular infiltrate, rich in T lymphocytes, 
which could provide a possible explanation for a presumptive vascular damage leading to 
ischemic or hemorrhagic consequences (25). 
9. Chronic encephalomyelitis 
The chronic forms of neuroborreliosis are rare and are preceded by acute unrecognized and 
untreated Lyme diseases. They represent 4-6% of neurolyme cases in Europe (6,7). The 
clinical spectrum can range from a progressive myelopathy to an encephalitic form 
manifested by seizures, focal deficit or cerebellar syndrome (9). Without treatment, there is 
no remission in the majority of cases. Medullar syndromes are most frequent (74-100%), 
associated with proprioceptive ataxia (63-100%), urinary dysfunction (37-62%) and/or 
para/tetraparesis (63-100%) (6). The chronic encephalitic form is rarer: cerebellar syndrome 
(26%), cognitive impairment/psychiatric symptoms (16%), hemiparesis (11%) (6). 
Like the other nervous system forms of Lyme, this chronic encephalomyelitis is frequently 
accompanied by cranial neuropathy (32-75%): II, VI, VII, VIII usually implicated. Unlike 
acute encephalitis, chronic encephalomyelitis can involve the optic nerve (6,9). Also, 
neurosensorial hearing loss is described in 6 patients with chronic Lyme disease in the study 
of Hansen et al. 
CSF analysis shows constantly a hyperproteinorahia (in average of 3,5g/l, but potentially as 
elevated as 10g/l), associated with lymphocytic pleiocytosis (7). In 70% of cases cerebral 
MRI is abnormal, showing subcortical or brainstem inflammatory lesions. Meningeal 
enhancement can also be found, sometimes as the sole finding. Rarely, lesions can be 
mistaken for multiple sclerosis (1). 
10. Lyme encephalopathy – A controversial entity 
The notion of Lyme encephalopathy is mostly exclusively found in American medical 
literature. The term was labeled in early studies that found that many patients with Lyme 
disease described fatigue, cognitive slowing, and memory difficulty (3). However, these 
symptoms are nonspecific and are frequent concomitants of many inflammatory disorders. 
They are not, in isolation, diagnostic of either Lyme disease or brain infection. In fact, the 
term “encephalopathy” was used to describe this state, since this term is most often used to 
indicate alterations in brain function due to non-neurologic causes. Subsequent work 
demonstrated that only in rare instances were these symptoms associated with brain 
infection (ie, encephalitis). In such cases, the diagnosis was readily confirmed by 
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cerebrospinal fluid abnormalities and brain MRI findings (3,12,26). According to experts, in 
the absence of such objective evidence of brain infection, these symptoms should not be 
considered evidence of nervous system infection with B. burgdorferi. 
Clinically, most often cited are: memory impairment (anterograde or retrograde), attention 
deficit, sleeping disorders (30%) and profound asthenia (70%) (27). Depression and/or 
irritability can be associated. Half of patients complain of headache. The neurologic exam in 
usually normal or signs of chronic axonal polyneuropathy can sometimes be found. 
Recently five case of dementia, with important impairment of mnesic and executive 
functions, have been reported in which a positive intratechal anti-Borrelia antibody index 
was found, in the absence of any other etiologic explanation (9).  
In those instances where nervous system infection can be demonstrated, standard 
antimicrobial therapy is effective. Multiple studies have shown that prolonged antimicrobial 
treatment offers such patients no lasting benefit but carries significant risk (28,29,30).  
Post Lyme disease syndrome versus chronic Lyme disease — A particular challenge has 
been the sizable population of individuals labeled as having "chronic Lyme disease" on the 
basis of nonspecific symptoms including persistent musculoskeletal pain, cognitive 
problems, and fatigue (31). In a minority of patients, these symptoms have followed 
microbiologically successful treatment of Lyme disease, a condition termed "post Lyme 
disease syndrome". However, all objective evidence indicates that these individuals, while 
suffering from debilitating symptoms, do not have chronic infection with B. burgdorferi and 
that antibiotic treatment is not beneficial (30). In its typical usage, “chronic Lyme disease” 
includes the post-Lyme disease syndrome, as well as illnesses and symptom complexes for 
which there is no convincing scientific evidence of any relationship to B. burgdorferi 
infection (5) and that are common enough in general population. The relationship between 
neuroborreliosis and cognitive impairment still remains to be proven and analyzed in 
prospective studies. 
11. Approach to diagnostic confirmation 
The diagnosis of central nervous system Lyme disease rests on three elements: 
 Possible exposure to Ixodes ticks, the only species capable of disease transmission 
 Objective evidence of central nervous system Lyme disease 
 Laboratory testing (positive Lyme serologies with positive cerebrospinal fluid [CSF] 
Lyme antibodies) which supports the diagnosis 
A positive blood Lyme serology does not always imply that the patient has an active Lyme 
disease. This serology shows that the patient has been in contact, at some time point, with 
the B. burgdorferi sensu lato (9). It does not mean that the microorganism has developed any 
pathogenic effect. In the general, healthy population the prevalence of positive Borrelia 
serology ranges between 3,3%-6%, depending of the study. In this context positive blood 
Lyme serology allows only an orientation for the diagnosis (32). 
Moreover the different laboratory techniques, with different reference values and variable 
intra-patient, inter-kit and inter-laboratory reproducibility, can sometimes be misleading.  
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In order to prevent these serologic diagnostic pitfalls, the US Centers for Disease Control 
and Prevention, recommends the “two-tier strategy”, which is uses a sensitive enzyme-
linked immunosorbent assay (ELISA) followed by a Western blot (5). An 
immunofluorescent assay (IFA) may be substituted for the ELISA. If the ELISA is positive or 
equivocal, then the same serum sample should be tested by Western blot (IgM and IgG 
immunoblots if early disease is suspected; IgG Western blot alone if late disease is 
suspected). If the ELISA is negative, the sample needs no further testing. 
With the exception of the first four to six weeks of infection, when the specific immune 
response may not yet have developed sufficiently to provide a measurable antibody 
response, serologic testing using the two-tier approach for antibodies to B. burgdorferi is 
highly sensitive and specific for the detection of antibodies. 
In patients with suspected central nervous system Lyme disease (ie, Lyme meningitis or 
encephalomyelitis), testing the CSF for intrathecal production of antibodies to B. 
burgdorferi is useful for establishing the diagnosis. This test is not applicable if involvement 
is limited to the peripheral nervous system. Even in central nervous system disease, the 
sensitivity remains unclear. A negative test for Lyme antibodies in the CSF does not exclude 
central nervous system Lyme disease. Rare cases with negative blood tests and positive CSF 
have been described, this possibly being due to very recent exposure (33). However such 
cases should be interpreted with caution.  
As in other infections, in nervous system Lyme disease, specific B cells may migrate to the 
central nervous system and proliferate locally, resulting in intrathecal production of 
antibodies to B. burgdorferi. However, even in the absence of nervous system Lyme disease, 
a substantial proportion of B. burgdorferi-specific antibodies diffuse from the serum to the 
CSF. Therefore, the presence of B. burgdorferi-specific antibodies in CSF does not itself 
establish the presence of central nervous system Lyme disease or prove that there is local 
production of antibodies (5).  
CSF B. burgdorferi antibody measurement is highly specific for nervous system Lyme 
disease, with cross-reactions occurring primarily in neurosyphilis (5). However, 
neurosyphilis usually results in production of reaginic antibodies in the CSF, such as those 
measured in the venereal disease research laboratory (VDRL) test, which is not the case for 
Lyme disease. Thus, differentiating between these two spirochetal infections is generally 
easy. 
Determination of test sensitivity is far more challenging, primarily because the studies that 
have addressed this issue have used quite different patient populations (17,34,35). In 
Europe, sensitivity for detecting anti-Borrelia antibodies in CSF is reportedly over 90 percent 
(33). Similarly, in some studies of Lyme meningitis from the United States, sensitivity was 
approximately 90 percent (36). However, in a more heterogeneous population of patients 
from the US, sensitivity was lower (34). In a patient with a clinical picture suggesting Lyme 
disease, a positive study from a reputable laboratory should be viewed as significant 
evidence in favor of the diagnosis (36). However, negative CSF studies should not eliminate 
neurologic Lyme disease from consideration if clinical circumstances support the diagnosis. 
The existing consensus is that the most appropriate test that allows with a specificity of 
more than 95% to attribute a neurologic syndrome to Lyme disease is the intrathecal anti-
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Borrelia antibody index. This index has a sensitivity of 75%, which is superior to culture 
and PCR. It implies that a blood and CSF sample be collected at the same time (17). A 
reference laboratory must indicate if the index is positive (in favor of neuroborreliosis), 
negative or intermediary. An European consensus exist for the utilization of this index in 
terms of specificity and sensitivity, in order to prevent inter-laboratory variables (17,33,37).  
In clinical practice, the first exam to be performed is Lyme blood serology. If positive or if 
negative in the presence of a highly evocative neurologic syndrome, lumbar puncture 
should be performed in order to determinate Lyme CSF serology and the intrathecal anti-
Borrelia antibody index (17). In children, in the presence of facial paralysis with positive 
blood Lyme serology, lumbar puncture is not necessary (9). The usefulness of the intrathecal 
anti-Borrelia index in uniquely peripheral forms of Lyme disease, has not yet been 
established. 
Although CSF or serum B. burgdorferi antibody concentrations typically decline after 
treatment, these antibodies may persist for 10 or more years following successful treatment 
(38,39,40). Thus, determination of active neuroborreliosis requires combining these results 
with less specific measures of active central nervous system inflammation (ie, a CSF 
pleocytosis and/or elevated protein). 
As in other infections in which there is a prominent antibody response, when nervous 
system Lyme disease has been present long enough for the B cell response to mature, there 
are often increases not only in specific anti-B. burgdorferi antibodies but also in nonspecific 
immunoglobulin concentrations. Consequently IgG synthesis rate or IgG index can be 
elevated, and, particularly in patients in Europe with central nervous system Lyme disease, 
oligoclonal bands can be seen in the CSF (40). The frequency with which these findings are 
found has varied widely among series. The important point is that oligoclonal bands and 
increased IgG synthesis occur in infections including central nervous system Lyme disease, 
and do not support a differential diagnosis with multiple sclerosis. 
Other diagnostic tests have been proposed, but are seldom used.  
Polymerase chain reaction — The polymerase chain reaction (PCR) for B. burgdorferi can 
be performed on CSF, although it has low sensitivity (41) probably reflecting the very low 
number of organisms typically present in spinal fluid. Between this low sensitivity, and a 
tendency for some laboratories to have difficulty avoiding false positives, the positive and 
negative predictive values both tend to be low, rendering this test of marginal utility. For 
that reason, PCR is not recommended for routine testing of CSF in Lyme disease 
CXCL13 — Although elevated concentrations of CXCL13, the chemokine B lymphocyte 
chemoattractant, are not unique to active nervous system Lyme disease, when combined 
with other diagnostic information, they might serve as a marker of disease activity or 
response to treatment (42). Like patients with neurosyphilis (43), patients with acute 
untreated nervous system Lyme disease and a CSF pleocytosis have elevated CSF 
concentrations of CXCL13 (44). Among 17 such patients, concentrations of CXCL13 were 
proportionately greater in CSF than in serum and were highly elevated in all CSF samples 
compared with the CSF of 178 controls without nervous system Lyme disease (mean 15,149 
pg/mL versus 247 pg/mL) (44). Five patients who had received at least two weeks of 
treatment for nervous system Lyme disease did not have substantially elevated CXCL13 
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concentrations (mean 202 pg/mL), whereas five patients who had been treated for less than 
two weeks had slightly elevated CXCL13 concentrations (mean 1412 pg/mL). Among the 
178 controls, seven had an elevated CXCL13 concentration, five with CNS lymphoma and 
two with bacterial meningitis. Relapsing-remitting multiple sclerosis has also been reported 
to cause elevated levels of CXCL13 in the CSF (45). 
These observations, coupled with polymerase chain reaction-based findings in patients with 
early nervous system Lyme disease (10), and the frequent description of increased 
immunoglobulin production including the presence of oligoclonal bands in CSF of 
neuroborreliosis patients, suggest that the spirochetes invade the central nervous system 
very early in infection and elicit a vigorous innate immunity-triggered B cell response, 
leading to prolonged antibody production. 
12. Treatment, evolution an reinfection 
Three antibiotic regimens have shown their efficacy in neuroborreliosis. In Europe 
Ceftriaxone iv 2g/day for 21-28 days remains of first intention. The Infectious Diseases 
Society of America and the American Academy of Neurology recommend a treatment 
duration of only 14 days, due to the lack of supporting evidence that a one month treatment 
is superior to a shorter, two weeks, regimen. In Europe, other options include Peniciline G 
18-24 MUI/day and Doxycycline 200 mg/day for an equal 21-28 days. Peniciline G is not 
recommended by the American Guidelines for neurologic Lyme disease. Resolution of 
symptoms under treatment can be rapid (within the first 48h) or delayed, after the first two 
weeks of antibiotic therapy. 90% of acute forms improve under treatment versus 40-50% of 
chronic forms (6). Facial paralysis or myelitis can persist as residual neurologic impairment 
after the end of treatment (9). As noted above, follow-up be serologic testing is of no use, as 
antibodies can still be detected after cure, even though they do not provide any kind of 
protection for reinfection. 
One single study proved the efficacy of a single dose flash therapy of 200mg of Doxycycline 
in the 72h that follow a tick bite in endemic areas (46). Taking into account the scare data 
available, the potential for adverse effects and cross resistance, the Lyme consensus 
conference of 2006 recommends the use of this strategy only in endemic areas and only if the 
infecting tick has remained attached for more than 48 hours (47). 
13. References 
[1] Blanc F; Gebly. Neurologic and psychiatric manifestations of Lyme disease Med Mal 
Infect. 2007 Jul-Aug;37(7-8):435-45. Epub 2007 Mar 9 
[2] Tranchant C, Warter JM. Lyme borreliosis, Rev Neurol (Paris). 2003 Jan;159(1):23-30 
[3] Halperin JJ, Krupp LB, Golightly MG, Volkman DJ, Lyme borreliosis-associated 
encephalopathy. Neurology. 1990;40(9):1340 
[4] Halperin, JJ, Heyes, MP, Keller, TL, Whitman, M. Neuroborreliosis - encephalopathy vs 
encephalitis. Proceedings of the Vth International Conference on Lyme Borreliosis, 
Arlington, Virginia, May 1992. Abstr. 1. 1992:1. 
[5] Halperin JJ, Nervous system Lyme disease, 2011 UpToDate, Inc, Last update juin 10, 
2011 
www.intechopen.com
 
Miscellanea on Encephalopathies 
 
66
[6] Hansen K, Lebech AM. The clinical and epidemiological profile of Lyme 
neuroborreliosis in Denmark 1985-1990. A prospective study of 187 patients with 
Borrelia burgdorferi specific intrathecal antibody production Brain. 1992 Apr;115 ( 
Pt 2):399-423 
[7] Oschmann P, Dorndorf W, Hornig C, Schäfer C, Wellensiek HJ, Pflughaupt KW. Stages 
and syndromes of neuroborreliosis. J Neurol. 1998 May;245(5):262-72. 
[8] Strle F, Ruzić-Sabljić E, Cimperman J, Lotric-Furlan S, Maraspin V. Comparison of 
findings for patients with Borrelia garinii andBorrelia afzelii isolated from 
cerebrospinal fluid, Clin Infect Dis. 2006 Sep 15;43(6):704-10. Epub 2006 Aug 8 
[9] De Seze J, Blanc F, Lyme neuroborreliosis: epidemiology, diagnosis and treatment, Lettre 
Infectiologue, XXVI (3) Mai-Juin 2011, 88-94  
[10] Luft BJ, Steinman CR, Neimark HC, et al. Invasion of the central nervous system by 
Borrelia burgdorferi in acute disseminated infection. JAMA 1992; 267:1364. 
[11] Logigian EL, Kaplan RF, Steere AC. Chronic neurologic manifestations of Lyme disease. 
N Engl J Med 1990; 323:1438. 
[12] Halperin JJ, Luft BJ, Anand AK, et al. Lyme neuroborreliosis: central nervous system 
manifestations. Neurology 1989; 39:753. 
[13] Logigian EL, Steere AC. Clinical and electrophysiologic findings in chronic neuropathy 
of Lyme disease. Neurology 1992; 42:303. 
[14] Rupprecht TA, Koedel U, Fingerle V, Pfister HW. The pathogenesis of lyme 
neuroborreliosis: from infection to inflammation. Mol Med 2008; 14:205. 
[15] Stanek G, Strle F, Lyme disease: European perspective. Infect Dis Clin North Am. 
2008;22(2):327 
[16] Halperin JJ, Golightly M. Lyme borreliosis in Bell's palsy. Long Island Neuroborreliosis 
Collaborative Study Group. Neurology 1992; 42:1268. 
[17] Blanc F, Jaulhac B, Fleury M, de Seze J, de Martino SJ, Remy V, Blaison G, Hansmann 
Y,Christmann D, Tranchant C Relevance of the antibody index to diagnose 
Lymeneuroborreliosis among seropositive patients, Neurology. 2007 Sep 
4;69(10):953-8. 
[18] Rothermel H, Hedges TR 3rd, Steere AC Optic neuropathy in children with Lyme 
disease. Pediatrics. 2001;108(2):477 
[19] Belman AL, Iyer M, Coyle PK, Dattwyler R Neurologic manifestations in children with 
North American Lyme disease, Neurology. 1993;43(12):2609 
[20] Blanc F, Froelich S, Vuillemet F, Carré S, Baldauf E, de Martino S, Jaulhac B, Maitrot 
D,Tranchant C, de Seze J., Acute myelitis and Lyme disease, Rev Neurol (Paris). 
2007 Nov;163(11):1039-47 
[21] Sibony P, Halperin J, Coyle PK, Patel K. Reactive Lyme serology in optic neuritis, J 
Neuroophthalmol. 2005 Jun;25(2):71-82 
[22] Krim E, Guehl D, Burbaud P, Lagueny A., Retrobulbar optic neuritis: a complication of 
Lyme disease? J Neurol Neurosurg Psychiatry. 2007 Dec;78(12):1409-10 
[23] Blanc F, Ballonzoli L, Marcel C, De Martino S, Jaulhac B, de Seze J. Lyme optic neuritis, J 
Neurol Sci. 2010 Aug 15;295(1-2):117-9. Epub 2010 Jun  
[24] Sparsa L, Blanc F, Lauer V, Cretin B, Marescaux C, Wolff V Recurrent ischemic strokes 
revealing Lymemeningovascularitis Rev Neurol (Paris). 2009 Mar;165(3):273-7. 
Epub 2008 Aug 28 
www.intechopen.com
Central Nervous System Involvement in Lyme Disease –  
Making the Diagnosis and Choosing the Correct Treatment 
 
67 
[25] Oksi J, Kalimo H, Marttila RJ, Marjamäki M, Sonninen P, Nikoskelainen J, Viljanen 
MK,Inflammatory brain changes in Lyme borreliosis. A report on three patients 
and review of literature. Brain. 1996 Dec;119 ( Pt 6):2143-54 
[26] Krupp LB, Masur D, Schwartz J, Coyle PK, Langenbach LJ, Fernquist SK, Jandorf L, 
Halperin JJ, Cognitive functioning in late Lyme borreliosis Arch Neurol. 
1991;48(11):1125 
[27] Logigian EL, Kaplan RF, Steere AC. Chronic neurologic manifestations of Lyme disease. 
N Engl J Med 1990; 323:1438 
[28] Klempner MS, Hu LT, Evans J, et al. Two controlled trials of antibiotic treatment in 
patients with persistent symptoms and a history of Lyme disease. N Engl J Med 
2001; 345:85. 
[29] Fallon BA, Keilp JG, Corbera KM, et al. A randomized, placebo-controlled trial of 
repeated IV antibiotic therapy for Lyme encephalopathy. Neurology 2008; 70:992. 
[30] Halperin JJ. Prolonged Lyme disease treatment: enough is enough. Neurology 2008; 
70:986. 
[31] Feder HM Jr, Johnson BJ, O'Connell S, et al. A critical appraisal of "chronic Lyme 
disease". N Engl J Med 2007; 357:1422. 
[32] Blanc F. Epidemiology of Lyme borreliosis and neuroborreliosis in France Rev Neurol 
(Paris). 2009 Aug-Sep;165(8-9):694-701. Epub 2009 May 17 
[33] Stiernstedt GT, Granström M, Hederstedt B, Sköldenberg B. Diagnosis of spirochetal 
meningitis by enzyme-linked immunosorbent assay and indirect 
immunofluorescence assay in serum and cerebrospinal fluid. J Clin Microbiol 1985; 
21:819. 
[34] Steere AC, Berardi VP, Weeks KE, et al. Evaluation of the intrathecal antibody response 
to Borrelia burgdorferi as a diagnostic test for Lyme neuroborreliosis. J Infect Dis 
1990; 161:1203. 
[35] Ljøstad U, Skarpaas T, Mygland A. Clinical usefulness of intrathecal antibody testing in 
acute Lyme neuroborreliosis. Eur J Neurol 2007; 14:873. 
[36] Halperin JJ, Volkman DJ, Wu P. Central nervous system abnormalities in Lyme 
neuroborreliosis. Neurology 1991; 41:1571. 
[37] Pícha D, Moravcová L, Zdárský E, Benes J. Clinical comparison of immunoblot and 
antibody index for detection of intrathecal synthesis of specific antibodies in 
Lymeneuroborreliosis Eur J Clin Microbiol Infect Dis. 2000 Oct;19(10):805-6. 
[38] Baig S, Olsson T, Hansen K, Link H. Anti-Borrelia burgdorferi antibody response over 
the course of Lyme neuroborreliosis. Infect Immun 1991; 59:1050. 
[39] Lakos A. CSF findings in Lyme meningitis. J Infect 1992; 25:155. 
[40] Hansen K, Cruz M, Link H. Oligoclonal Borrelia burgdorferi-specific IgG antibodies in 
cerebrospinal fluid in Lyme neuroborreliosis. J Infect Dis 1990; 161:1194. 
[41] Nocton JJ, Bloom BJ, Rutledge BJ, et al. Detection of Borrelia burgdorferi DNA by 
polymerase chain reaction in cerebrospinal fluid in Lyme neuroborreliosis. J Infect 
Dis 1996; 174:623. 
[42] Tumani H, Cadavid D. Are high CSF levels of CXCL13 helpful for diagnosis of Lyme 
neuroborreliosis? Neurology 2011; 76:1034. 
[43] Marra CM, Tantalo LC, Sahi SK, et al. CXCL13 as a cerebrospinal fluid marker for 
neurosyphilis in HIV-infected patients with syphilis. Sex Transm Dis 2010; 37:283. 
www.intechopen.com
 
Miscellanea on Encephalopathies 
 
68
[44] Schmidt C, Plate A, Angele B, et al. A prospective study on the role of CXCL13 in Lyme 
neuroborreliosis. Neurology 2011; 76:1051. 
[45] Rupprecht TA, Pfister HW, Angele B, et al. The chemokine CXCL13 (BLC): a putative 
diagnostic marker for neuroborreliosis. Neurology 2005; 65:448. 
[46] Nadelman RB, Nowakowski J, Fish D, Falco RC, Freeman K, McKenna D, Welch P, 
Marcus R, Agüero-Rosenfeld ME, Dennis DT, Wormser GP; Tick Bite Study Group 
Prophylaxis with single-dose doxycycline for the prevention of Lymedisease after 
an Ixodes scapularis tick bite. N Engl J Med. 2001 Jul 12;345(2):79-84 
[47] Clavelou P.Consensus conference on Lyme borreliosis.Presse Med. 2008 
Dec;37(12):1707-8. Epub 2008 Nov 1 
www.intechopen.com
Miscellanea on Encephalopathies
Edited by Dr. Radu Tanasescu
ISBN 978-953-51-0499-5
Hard cover, 202 pages
Publisher InTech
Published online 18, April, 2012
Published in print edition April, 2012
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
The book project “Miscellanea on Encephalopathies” aims to cover some of the important aspects of
infectious-related encephalopathies, post-transplantation and drug-induced encephalopathies, by transmitting
valuable information filtered through the real life clinical and research experience of the authors.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Ruxandra Calin, Adriana Hristea and Radu Tanasescu (2012). Central Nervous System Involvement in Lyme
Disease - Making the Diagnosis and Choosing the Correct Treatment, Miscellanea on Encephalopathies, Dr.
Radu Tanasescu (Ed.), ISBN: 978-953-51-0499-5, InTech, Available from:
http://www.intechopen.com/books/miscellanea-on-encephalopathies/central-neurological-manifestations-of-
lyme-disease-encephalopathy-and-more
© 2012 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
